Investing in
Life Sciences

We drive bold smart solutions to extend 
longevity

PRESS RELEASE

BIOVIVA, GENE THERAPY AND BLOCKCHAIN MERGES IN RUSSIA
BioViva USA Inc. files for patent for dual gene therapy to restore telomere attrition and muscle degradation caused by aging.
July 07, 2016